Regardless, no prior studies have specifically reported germline CHEK2 alterations in subependymal giant cell tumors or medulloblastomas, although CHEK2 germline alterations have been identified in patients with glioblastoma [20,40] and other pediatric brain tumors [41,42,43]. The gene discussed is CHEK2; the disease is glioblastoma.